ABCB1 polymorphisms associated with osteonecrosis of the femeral head

被引:0
作者
Zhang, Zongyu [1 ]
Li, Yawei [1 ]
Liu, Huaiying [1 ]
Shi, Jinhui [2 ]
Li, Xuefeng [2 ]
Jiang, Weimin [2 ]
机构
[1] Nanjing Univ Chinese Med, Lianyungang Affiliated Hosp, Nanjing, Jiangsu, Peoples R China
[2] Suzhou Univ, Affiliated Hosp 1, Suzhou 215006, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2015年 / 8卷 / 11期
关键词
ABCB1; polymorphisms; ONFH; SINGLE-NUCLEOTIDE POLYMORPHISMS; FACTOR-V-LEIDEN; FEMORAL-HEAD; IDIOPATHIC OSTEONECROSIS; KOREAN POPULATION; GENE MUTATION; HYPOFIBRINOLYSIS; IDENTIFICATION; HYPERTENSION; RESISTANCE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: This case-control study was conducted to investigate the relation of ATP-binding cassette subfamily B member 1 (ABCB1) C1236T and C3435T polymorphisms and non-traumatic osteonecrosis of the femeral head (ONFH). Methods: We gathered 113 ONFH patients and 116 controls in the study. The polymorphisms of ABCB1 were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technology. Odds ratio (OR) with 95% confidence interval (CI) were adopted to analyze the correlation between ABCB1 polymorphisms and ONFH. Results: In the study, we found that the frequency of C3435T TT genotype was much lower in case group, compared with that of controls (17.7% vs. 23.3%). Moreover, OR and 95% CI values indicated that C3435T TT genotype served as a protective factor for ONFH (OR=0.34, 95% CI=0.15-0.75). Meanwhile, the risk for the T allele carriers was much lower than C allele (OR=0.60, 95% CI=0.42-0.87). However, C1236T polymorphism showed no significant effects on the pathogenesis of ONFH. In the haplotype analysis, T-T haplotype appeared to be an inhibitor for ONFH (OR=0.45, 95% CI=0.23-0.87). Conclusions: Based on the results, ABCB1 polymorphisms were associated with the risk for ONFH.
引用
收藏
页码:15240 / 15244
页数:5
相关论文
共 50 条
  • [42] Pharmacogenetics and Treatment Response in Narcolepsy Type 1: Relevance of the Polymorphisms of the Drug Transporter Gene ABCB1
    Moresco, Monica
    Riccardi, Laura Natalia
    Pizza, Fabio
    Zenesini, Corrado
    Caporali, Leonardo
    Plazzi, Giuseppe
    Pelotti, Susi
    CLINICAL NEUROPHARMACOLOGY, 2016, 39 (01) : 18 - 23
  • [43] The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation
    Ji, Qiuyi
    Zhang, Chunyu
    Xu, Qing
    Wang, Zi
    Li, Xiaoye
    Lv, Qianzhou
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (05) : 2247 - 2255
  • [44] The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia
    Galimberti, Sara
    Bucelli, Cristina
    Arrigoni, Elena
    Barate, Claudia
    Grassi, Susanna
    Ricci, Federica
    Guerrini, Francesca
    Ciabatti, Elena
    Fava, Carmen
    D'Avolio, Antonio
    Fontanelli, Giulia
    Cambrin, Giovanna Rege
    Isidori, Alessandro
    Loscocco, Federica
    Caocci, Giovanni
    Greco, Marianna
    Bocchia, Monica
    Aprile, Lara
    Gozzini, Antonella
    Scappini, Barbara
    Cattaneo, Daniele
    Scortechini, Anna Rita
    La Nasa, Giorgio
    Bosi, Alberto
    Leoni, Pietro
    Danesi, Romano
    Saglio, Giuseppe
    Visani, Giuseppe
    Cortelezzi, Agostino
    Petrini, Mario
    Lurlo, Alessandra
    Di Paolo, Antonello
    ONCOTARGET, 2017, 8 (50) : 88021 - 88033
  • [45] Haplotype-Based Analysis of MDR1/ABCB1 Gene Polymorphisms in a Turkish Population
    Gumus-Akay, Guevem
    Rustemoglu, Aydin
    Karadag, Aynur
    Sunguroglu, Asuman
    DNA AND CELL BIOLOGY, 2010, 29 (02) : 83 - 90
  • [46] The controversial association of ABCB1 polymorphisms in refractory epilepsy:: An analysis of multiple SNPs in an Irish population
    Shahwan, Amre
    Murphy, Kevin
    Doherty, Colin
    Cavalleri, Gianpiero L.
    Muckian, Clare
    Dicker, Pat
    McCarthy, Mary
    Kinirons, Peter
    Goldstein, David
    Delanty, Norman
    EPILEPSY RESEARCH, 2007, 73 (02) : 192 - 198
  • [47] Association of ABCB1 polymorphisms with lipid homeostasis and liver injury response to atorvastatin in the Chinese population
    Qu, Kan-Kan
    Zhang, Chen-Ning
    Dong, Li-Xia
    Wang, Shu-Shan
    Zhang, Zhong-Dong
    Zhang, Lin
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (01) : 15 - 22
  • [48] Pharmacogenetic Study of the Impact of ABCB1 Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients
    Chernov, Alexandr
    Kilina, Daria
    Smirnova, Tatiana
    Galimova, Elvira
    PHARMACEUTICS, 2022, 14 (11)
  • [49] Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipients
    Sun, Bo
    Guo, Yankun
    Gao, Junwei
    Shi, Weifeng
    Fan, Guorong
    Li, Xiaoyu
    Qiu, Jianxin
    Qin, Yan
    Liu, Gaolin
    PHARMACOGENOMICS, 2017, 18 (16) : 1503 - 1513
  • [50] Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies
    Han, Jian
    Liu, Lu
    Meng, Li
    Guo, Huan
    Zhang, Jin
    Han, Zhi-Qiang
    Hong, Zhen-Ya
    FRONTIERS IN ONCOLOGY, 2021, 11